NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer | Experimental oncology
Review NFKB and NFKBI polymorphisms in relation to susceptibility of tumour and other diseases
NFKB1 −94ins/delATTG polymorphism is a novel prognostic marker in first line‐treated multiple myeloma - Varga - 2015 - British Journal of Haematology - Wiley Online Library
NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell Lung Cancer Risk and Overall Survival | Scientific Reports
Genes | Free Full-Text | Genetics and Epigenetics in Allergic Rhinitis
NFKB1 gene rs28362491 ins/del variation is associated with higher susceptibility to myocardial infarction in a Chinese Han population | Scientific Reports
Frontiers | Germline Genetic Variants of Viral Entry and Innate Immunity May Influence Susceptibility to SARS-CoV-2 Infection: Toward a Polygenic Risk Score for Risk Stratification
Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers - eBioMedicine
Frontiers | Potentially functional variants of MAP3K14 in the NF-κB signaling pathway genes predict survival of HBV-related hepatocellular carcinoma patients
Functional Promoter -94 ins/del ATTG Polymorphism in NFKB1 Gene Is Associated with Bladder Cancer Risk in a Chinese Population | PLOS ONE
Potential prognostic markers and significant lncRNA–mRNA co-expression pairs in laryngeal squamous cell carcinoma
NF-kB as a potential prognostic marker and a candidate for targeted therapy of cancer | Experimental oncology
Cancers | Free Full-Text | A Role for NF-κB in Organ Specific Cancer and Cancer Stem Cells
NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53 | Modern Pathology
Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population | Scientific Reports
Cancers | Free Full-Text | Targeting NF-κB Signaling for Multiple Myeloma
Cell-free DNA as a novel marker in cancer therapy | Biomarkers in Medicine
Development of Novel Cancer Biomarkers for Diagnosis and Prognosis | SpringerLink
Frontiers | Deciphering a mitochondria-related signature to supervise prognosis and immunotherapy in hepatocellular carcinoma
IJMS | Free Full-Text | The Emerging Role of TXNIP in Ischemic and Cardiovascular Diseases; A Novel Marker and Therapeutic Target
Functional Promoter -94 ins/del ATTG Polymorphism in NFKB1 Gene Is Associated with Bladder Cancer Risk in a Chinese Population | PLOS ONE
Novel archetype in psoriasis management bridging molecular dynamics in exploring novel therapies - ScienceDirect
Full article: Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma
NFKB1 −94ins/delATTG polymorphism is a novel prognostic marker in first line‐treated multiple m
The roles of long non-coding RNAs in lung cancer
